Computerized system for communicating processing information to a user

The computerized system addresses the mental load issue in existing diabetic treatment systems by determining medication dosages and issuing adaptive notifications based on disturbance thresholds, enhancing user security and reducing overall disruption.

FR3133478B1Active Publication Date: 2024-11-29DIABELOOP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
FR2022002161
Authority / Receiving Office
FR · FR
Patent Type
Patents
Current Assignee / Owner
Filing Date
2022-03-11
Publication Date
2024-11-29
Estimated Expiration
2042-03-11

AI Technical Summary

Technical Problem

Existing systems for communicating treatment information to diabetic patients, such as those described in US9439602B2, do not adequately consider the mental load imposed on users and fail to provide timely notifications in critical situations, potentially leading to increased user distress.

Method used

A computerized system that determines medication dosages based on user metabolite data, using a processor to evaluate disturbance thresholds (BT, IT, TT) and issue notifications via sound, light, or vibration, with adaptive thresholds to minimize user disruption.

Benefits of technology

The system reduces mental load by providing targeted and timely notifications, improving user security and maintaining a balance between user safety and disruption through adaptive threshold settings.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000019_0000
    Figure 00000019_0000
  • Figure 00000019_0001
    Figure 00000019_0001
  • Figure 00000020_0000
    Figure 00000020_0000
Patent Text Reader

Abstract

A computerized system for communicating treatment information to a user. The computerized system (1) comprises a memory (22) storing data including user metabolite time-series data and a processor (23). The processor (23) comprises a dose-determination module (24) adapted to determine a possible drug dosage based on said data, a perturbation module (25) adapted to determine whether said data or the possible drug dosage triggers at least one perturbation threshold from among a plurality of perturbation thresholds, and a notification module (26) adapted to, when the perturbation module (25) determines that at least one perturbation threshold is triggered or when at least one perturbation bypass is triggered, issue a user notification, the user notification being issued to the user and including the possible drug dosage.The plurality of disturbance thresholds includes a bolus threshold, a drug threshold, and a time threshold. Figure for the abbreviation: Figure 1.
Need to check novelty before this filing date? Find Prior Art

Description

Title of the invention: Computerized system for communicating processing information to a user FIELD OF THE INVENTION

[0001] The present invention relates to a computerized system for communicating treatment information to a user. TECHNOLOGICAL BACKGROUND

[0002] More specifically, the present invention relates to a computerized system for communicating treatment information to a user and an associated method.

[0003] As disclosed in US7713229B2, drug infusion devices and devices for monitoring physiological fluid characteristics are known in the medical field. A very common application of such devices is the administration of insulin and the monitoring of blood glucose levels of diabetic patients. The increased portability and ease of use of these devices has enabled the diabetic patient to administer a self-regulated medical treatment regimen which, in turn, provides an increased level of autonomy and privacy to the patient. This is particularly advantageous given that the glucose levels of a diabetic patient may vary frequently throughout the day.

[0004] Thus, it is important to provide the patient with information in an intelligent manner. Document US9439602B2 describes a blood glucose monitoring system alerting a user based on clinical risk,

[0005] as a measure of the severity of a specific glycemic condition, which depends mainly on the glucose level, but can also be influenced by other factors, such as the glucose trend and possibly the amount of insulin present in the patient's body. In particular, when assessing the "clinical risk" to which the patient is exposed, not only the glycemic level but also its trend should be considered. In particular, a device that triggers alarms based on information from the glucose sensor and a critical risk should exploit technologies that can be integrated on a small PDA platform.

[0006] However, document US9439602B2 does not take into consideration the mental load involved by a system taking into account only an arbitrary clinical risk.

[0007] The present invention aims to provide a computerized system for communicating processing information to a user and an associated method capable of issuing a notification to the user while reducing said mental load. Summary of the invention

[0008] Thus, the invention relates to a computerized system for communicating processing information to a user, in which the computerized system comprises: . a memory storing data including, at least, temporal data of user metabolites; . a processor comprising: - a dose determination module adapted to determine a possible dosage of medication on the basis of said data; - a disturbance module adapted to determine whether said data or the possible dosage of medication triggers at least one disturbance threshold among a plurality of disturbance thresholds; - a notification module adapted to, when the disturbance module determines that the at least one disturbance threshold is triggered or when at least one disturbance bypass is triggered, issue a user notification, the user notification being issued to the user and including the possible dosage of medication; wherein the plurality of disturbance thresholds comprises: . a bolus threshold hereinafter referred to as BT, the BT corresponding to a minimum possible dosage of medication; . a drug threshold hereinafter referred to as IT, the IT corresponding to a minimum possible dosage of drug; and . a time threshold hereinafter referred to as TT, the TT corresponding to a minimum amount of time elapsed since a previous user notification issued to a user or a previous bolus administered to the user.

[0009] According to the present invention, a disruptive bypass is a situation in which the user must receive processing information as soon as possible and therefore cannot wait for at least one disruption threshold to be triggered. A disruptive bypass could be a situation where the user is facing severe hyperglycemia for example.

[0010] According to the present invention, the dosage of the drug corresponds to an insulin dosage recommendation.

[0011] According to the present invention, issuing a user notification means sending a notification to a user. Said user notification may be accompanied by notifying elements such as any type of sound, light or vibration. According to one embodiment, the more important the user notification, the more notification elements it will be accompanied by.

[0012] According to one embodiment, the user's temporal metabolite data is provided by a continuous glucose monitoring sensor.

[0013] According to one embodiment, the possible dosage of medication determined by the dose determination module can be viewed at any time by the user.

[0014] According to the present invention, the drug threshold is an insulin threshold.

[0015] Having at least one disruptive bypass allows a user notification to be issued to the user in different situations and therefore improves user security.

[0016] Having a BT makes it possible to issue a user notification and therefore to disturb the user only if the determined possible dosage of medication is greater than a minimum administrable quantity of insulin using the user's preferred administration method and device. Indeed, some devices only allow a single unit of insulin to be administered, so it is not relevant to issue a notification to the user and disturb the user for a determined possible dosage of medication that cannot be administered to him.

[0017] According to an embodiment in which the system is connected to a dispensing device such as a smart insulin pen, the BT is a predetermined value corresponding to the minimum amount of insulin administrable using the administration method and the dispensing device.

[0018] Having an IT allows a user notification to be issued and thus the user to be disturbed only to substantially correct the blood sugar. For example, when the user is lacking insulin, an IT could be equal to an amount of insulin having the effect of reducing the user's blood sugar by three mg / dl. Thus, if a possible dosage of medication were calculated to correct the blood sugar by a value less than three mg / dl, ITT would not be triggered so no user notification would be issued and the user would not be disturbed.

[0019] According to one embodiment, ITT is a predetermined value corresponding to a choice of the user.

[0020] Having a TT makes it possible to issue a user notification and therefore only disturb the user after a certain amount of time has passed since the last user notification issued and / or since the last bolus received by the user and therefore reduce the overall disturbance by the system.

[0021] According to the present invention, a received bolus corresponds to a certain dose of insulin injected / administered into the user's body.

[0022] According to a preferred embodiment, the TT corresponds to a minimum amount of time elapsed since the previous bolus was administered to the user.

[0023] According to one embodiment, the notification module is adapted for, when the disturbance module determines that at least the BT and the TT are triggered or when at least one disruptive bypass is triggered, issue a user notification.

[0024] Such a configuration potentially minimizes the overall disruption by the system because it potentially reduces the number of user notifications issued according to the BT and HT.

[0025] According to one embodiment, the notification module is adapted to, when the disturbance module determines that at least the BT, the IT and the TT are triggered or when at least one disturbance bypass is triggered, issue a user notification.

[0026] Such a configuration potentially minimizes the overall disruption by the system because it potentially reduces the number of user notifications issued according to the BT, IT and TT.

[0027] According to one embodiment, the IT depends on a minimum blood sugar level to be corrected and a compensation factor.

[0028] According to one embodiment, IT is as follows: [Math 1] IT = AGmin x CF / 100; in which

[0029] AGmin represents a minimum blood sugar level to be corrected; and

[0030] CF represents a compensation factor [U / g / L].

[0031] Such a configuration makes it possible to precisely determine the IT.

[0032] According to one embodiment, the compensation factor is derived from the user's total daily insulin dose hereinafter referred to as TDD with [Math 2] CF = TDD / 18. Such a configuration makes it possible to accurately determine the compensation factor.

[0033] According to one embodiment, the BT decreases based on the amount of time elapsed since a previous user notification was issued to a user or a previous bolus was administered to the user.

[0034] According to a preferred embodiment, the BT decreases depending on the amount of time elapsed since a previous bolus was administered to the user.

[0035] Such a configuration allows for maintaining a good balance between user safety and user disruption. Indeed, having a decreasing BT based on the amount of time elapsed since a previous bolus was administered to the user allows for issuing a user notification to the user even if a short period of time has elapsed since the previous user notification was issued or the previous bolus was administered if the possible dosage of medication is well above the TI or if the user blood glucose level could be outside an acceptable range in the future, for example.

[0036] According to one embodiment, the BT decreases from a maximum insulin value, said maximum insulin value depending on the physiological impact of a unit of insulin on the user. Such a configuration allows the system to adapt to the user. According to one embodiment, the BT decreases from a maximum value, said maximum insulin value being equal to [Math 3] min (xU, xCF), where xU corresponds to a maximum quantity of insulin units and xCF is a compensation factor multiplied by a constant in order to take into account the user's insulin needs.

[0037] According to one embodiment, xU is a pre-recorded value between two and eight units of insulin.

[0038] According to one embodiment, the BT has a minimum insulin value after a certain amount of time has elapsed since a previous user notification was issued to a user or a previous bolus was administered to the user.

[0039] According to a preferred embodiment, the BT cannot decrease more than a minimum insulin value. BT is equal to said minimum insulin value after a certain period of time has elapsed since a previous bolus was administered to the user.

[0040] Such a configuration makes it possible to maintain a good balance between user safety and user disruption. Indeed, having a minimum value after a certain period of time makes it possible not to issue a user notification containing a medication dosage that is too low to be relevant, even if the time elapsed since the last user notification issued or bolus administered is significantly greater than the TT.

[0041] According to one embodiment, the BT has a minimum insulin value, said minimum insulin value depending on the physiological impact of a unit of insulin on the user and a user preference. Such a configuration allows the system to adapt to the user. According to one embodiment, the BT has a minimum insulin value, said minimum insulin value being equal to [Math 4] max (yU, pU, yCF), where yU corresponds to a minimum amount of insulin units which could, in a specific embodiment, be linked to the user's preferred delivery mode and device, pU corresponds to an amount of insulin units according to a user preference and yCF being a compensation factor multiplied by a constant in order to take into account the user's insulin needs.

[0042] According to one embodiment, yU is a pre-recorded value between half a unit of insulin and 2 units of insulin.

[0043] According to one embodiment, the BT depends on a maximum insulin value, a maximum blood glucose level to be corrected, a minimum insulin value, an insulin value taking into account the compensation factor and a secondary compensation factor which may be equal to the compensation factor. A compensation factor is secondary which can be equal to the compensation factor allows the system to adapt more to the user.

[0044] Such a preferred embodiment allows for maintaining a better balance between user safety and user disruption.

[0045] According to one embodiment, a disruptive bypass is an emergency bypass, said emergency bypass being triggered when a risk to the user is identified from the data.

[0046] Such a configuration makes it possible to bypass the triggering of any threshold and therefore the safety of the user.

[0047] According to one embodiment, an emergency may be when a current determined and / or estimated user onboard insulin is below a certain value. Therefore, the notification module is adapted to issue a user notification including a possible medication dosage when the current user onboard insulin is below a certain value. According to one embodiment, the onboard insulin is determined and / or estimated based on the user's previously injected insulin, insulin consumption over time, and time.

[0048] According to one embodiment, the on-board insulin is determined using, at least, a mathematical model representing the evolution of the on-board insulin over time as a function of the insulin previously injected into the user, insulin consumption over time and time.

[0049] The present invention also relates to a method for communicating processing information to a user, characterized in that the method is implemented by a computerized system and comprises the following steps: - receiving data, the step of receiving data comprising receiving data comprising at least user metabolite time data; - drug dosage determination, the drug dosage determination step consisting of determining a possible drug dosage from said data; - trigger determination, the trigger determination step of determining whether said data or the possible dosage of medication triggers at least one disturbance threshold among a plurality of disturbance thresholds; and - issuing a notification, the notification issuing step consisting of issuing a user notification to a user when it is determined, during the trigger determination step, that at least one threshold among the plurality of disturbance thresholds is triggered or when at least one disturbance bypass is triggered, the user notification comprising the possible dosage of medication; wherein the plurality of disturbance thresholds comprises: . a bolus threshold hereinafter referred to as BT, the BT corresponding to a minimum bolus dose . a drug threshold hereinafter referred to as IT, HT corresponding to a minimal dose of insulin; and . a time threshold hereinafter referred to as TT, the TT corresponding to a minimum amount of time elapsed since a previous user notification delivered to a user or a previous bolus administered to the user.

[0050] According to one embodiment, all the characteristics and advantages described previously applicable to the computerized system are also applicable to the method.

[0051] According to one embodiment, the method is implemented by the system for communicating processing information to a user previously described.

[0052] According to one embodiment, the notification transmission step consists of transmitting a user notification to a user when it is determined, during the triggering determination step, that at least the BT and the TT are triggered or when at least one disruptive bypass is triggered.

[0053] According to one embodiment, the notification transmission step consists of transmitting a user notification to a user when it is determined, during the triggering determination step, that at least the BT, the IT and the TT are triggered or when at least one disruptive bypass is triggered.

[0054] According to one embodiment, the IT depends on a minimum blood sugar level to be corrected and a compensation factor.

[0055] According to one embodiment, the BT decreases based on the amount of time elapsed since a previous user notification was issued to a user or a previous bolus was administered to the user.

[0056] According to one embodiment, the BT has a minimum value after a certain duration of time has elapsed since a previous user notification was issued to a user or a previous bolus was administered to the user.

[0057] According to one embodiment, a disruptive bypass is an emergency bypass, said emergency bypass being triggered when a risk to the user is identified from the data.

[0058] The present invention also relates to a computer program product comprising instructions which, when the program is executed by a computer, cause the computer to execute the steps of the method described above.

[0059] According to the present invention, the term "insulin" could be understood as any type of drug. Brief description of the drawings

[0060] Embodiments of the invention will be described below with reference to drawings, briefly described below:

[0061] [Fig.l] represents a schematic view of a computerized system for communicating processing information to a user according to the present invention;

[0062] [Fig.2] represents the steps of a method of communicating information from treatment to a user according to the present invention; and

[0063] [Fig.3] shows a drug dosing system according to the present invention. DETAILED DESCRIPTION

[0064] [Fig. 3] shows an example of a drug dosing system 1. The drug dosing system 1 will be described in connection with an application for diabetes. However, other applications of the invention are possible. The drug dosing system 1 comprises a sensing unit 2 adapted to measure a user parameter such as time data of user metabolites, in the present example, the sensing unit 2 is a continuous glucose monitoring sensor. In particular, the sensing unit 2 may comprise a wearable accessory, which is worn by the user. In addition, the sensing unit 2 is adapted to repeatedly provide a measurement of the user parameter. The sensing unit 2 may comprise a clock, so that time data is associated with measurement data. Such sensing units may be referred to as continuous sensing units.The detection unit 2 may be adapted to carry out in vivo measurements. Thus, the measured parameter may be a concentration of a metabolite, such as, for example, glucose.

[0065] The detection unit 2 comprises a data communication device adapted to communicate data to a remote system. The data communication device may be adapted to communicate wirelessly, for example using short-range radio communication corresponding to the Bluetooth® standard or the BLE standard at the priority date of the patent application.

[0066] The drug dosing system 1 further comprises a terminal 3. The terminal 3 comprises a computerized system 1 for communicating treatment information to a user. Said computerized system 1, as shown in [Fig.l], comprises a processor 23 and a memory 22. The terminal 3 comprises a data communication module 27 adapted to communicate data to a remote system. The data communication module 27 could be adapted to communicate wirelessly, for example using short-range radio communication corresponding to the Bluetooth® standard at the priority date of the patent application. For example, the data communication module 27 of the terminal 3 and the data communication device of the detection unit 2 are compatible with each other, to form a communication system, by which the terminal 3 and the detection unit detection unit 2 communicate with each other. In particular, measurement data, and possibly time data of user metabolites, are communicated from the detection unit 2 to the terminal 3, and stored in the memory 22.

[0067] As described in [Fig. 3], the drug dosing system 1 further comprises a drug dispensing device 4. The drug dispensing device 4 comprises a container 5 configured to contain a drug. Typically, the container 5 comprises more than one dose of drug, so as to be used several times. The drug dispensing device 4 further comprises a dispensing unit 6 adapted to dispense a drug to the user. This comprises for example a needle to be inserted into the user's body, and a plunger 8 which can be pushed to expel the drug from the container 5 through the needle into the user's body. The drug dispensing device 4 further comprises an adjustment unit 7. The adjustment unit 7 can be adjusted by the user in order to control the amount of drug which can be injected at a time using the drug dispensing device 4.For example, the adjustment unit 7 may be set by the user to a quantity of, for example, two units, and the delivery system is operated to dispense the medicament and is prevented from operating when two units have been injected. For example, an adjustable mechanical stop for the plunger 8 may be used. Other embodiments are possible.

[0068] However, if the setting unit 7 does not allow setting a quantity of medicine less than one unit, the user cannot receive an injection of less than one unit.

[0069] [Fig.l] shows an example of computerized communicating treatment information configured to communicate treatment information such as a possible medication dosage to a user. More specifically, the medication dosage corresponds to an insulin dosage recommendation. The computerized system 1 comprises a memory 22 configured to store data sent by the detection unit 2 comprising, at least, user metabolite time data and a processor 23.The processor 23 comprises a dose determination module 24 adapted to determine a possible dosage of medication from said data, a disturbance module 25 adapted to determine whether said data or the possible dosage of medication triggers at least one disturbance threshold among a plurality of disturbance thresholds and a notification module 26 adapted to, when the disturbance module 25 determines that the at least one disturbance threshold is triggered or when at least one disturbance bypass is triggered, issue a user notification, the user notification being issued to the user and comprising the possible dosage of medication. According to the present invention, a disturbance bypass is a situation in which the user . must receive processing information as soon as possible and therefore cannot wait for at least one disturbance threshold to be triggered. Having at least one disturbance bypass allows for user notification to be issued to the user in different situations and therefore improves user safety.

[0070] The expression “issuing a user notification” specifically means “sending a notification to a user”. Said user notification may be accompanied by notifying elements such as any type of sound, light or vibration. According to one embodiment, the more important the user notification, the more it will be accompanied by notification elements. However, when there is no disturbance threshold or disruptive bypass, the possible dosage of medication determined by the dose determination module 24 can be consulted at any time by the user on the terminal 3.

[0071] A disruptive bypass could be a situation where the user is facing severe hyperglycemia for example. A disruptive bypass is an emergency bypass, said emergency bypass being triggered when a risk to the user is identified from the data. Such a configuration allows to bypass the triggering of any threshold and thus the safety of the user. According to one embodiment, an emergency may occur when a current determined and / or estimated user onboard insulin is below a certain value. Therefore, the notification module 26 is adapted to issue a user notification including a possible dosage of medication when the current user onboard insulin is below a certain value.According to one embodiment, the on-board insulin is determined and / or estimated based on the insulin previously injected to the user, insulin consumption over time and time. According to one embodiment, the on-board insulin is determined using at least one mathematical model representing the evolution of the on-board insulin over time based on the insulin previously injected to the user, insulin consumption over time and time.

[0072] The plurality of disturbance thresholds includes a bolus threshold hereinafter referred to as BT, the BT corresponding to a minimum bolus dose. Having a BT makes it possible to issue a user notification and therefore to disturb the user only if the determined possible dosage of medication is greater than a minimum administrable quantity of insulin using the user's preferred administration method and device. Indeed, as indicated previously, certain devices only allow the administration of a single unit of insulin, it is therefore not relevant to issue a notification to the user and disturb the user for a determined possible dosage of medication which cannot be administered to him. According to an embodiment in which the system is connected to a dispensing device 4 such as an insulin pen intelligent, the BT is a predetermined value corresponding to the minimum administrable quantity of insulin using the administration method and the dispensing device 4.

[0073] According to a preferred embodiment, the BT decreases as a function of the amount of time elapsed since a previous bolus was administered to the user. Such a configuration allows for maintaining a good balance between user safety and user disruption. Indeed, having a BT decreasing as a function of the amount of time elapsed since a previous bolus was administered to the user allows for issuing a user notification to the user even if a short amount of time has elapsed since the previous user notification was issued or the previous bolus was administered if the possible dosage of medication is well above the IT or if a user's blood glucose level might be outside an acceptable range in the future, for example.The BT decreases from a maximum insulin value, said maximum insulin value depending on the physiological impact of one unit of insulin on the user, and is equal to [Math 5] min(xU, xCF), where xU corresponds to a maximum amount of insulin units, xU is a pre-stored value between two and eight units of insulin, and xCF is a compensation factor multiplied by a constant in order to take into account the user's insulin needs. Such a configuration allows the system to adapt precisely to the user.

[0074] The plurality of disturbance thresholds also includes a medication threshold, and more specifically an insulin threshold hereinafter referred to as IT, ITT corresponding to a minimum dose of insulin. Having an IT makes it possible to issue a user notification and therefore to only disturb the user for a substantial quantity of insulin. A substantial quantity of insulin being an amount of insulin having the effect of significantly lowering blood sugar. For example, when the user is lacking insulin, an IT could be equal to an amount of insulin having the effect of reducing the user's blood sugar by three mg / dl. Thus, if a possible dosage of medication were calculated to correct the blood sugar by a value lower than three mg / dl, the IT would not be triggered, therefore no user notification would be issued and the user would not be disturbed.According to one embodiment, the IT is a predetermined value corresponding to a choice and / or a preference of the user.

[0075] According to a preferred embodiment, the IT depends on a minimum blood glucose level to be corrected and a compensation factor. Therefore, IT is defined as follows: [Math 6] IT = AGmin x CF / 100 ; in which

[0076] AGmin represents a minimum blood sugar level to be corrected; and

[0077] CF represents a compensation factor [U / g / L].

[0078] Such a configuration makes it possible to precisely determine the IT. According to one embodiment, the compensation factor is derived from the total daily dose user's insulin hereinafter referred to as TDD with [Math 7] CF=TDD / 18. Such a configuration allows the compensation factor to be determined accurately.

[0079] The BT has a minimum insulin value after a certain amount of time has elapsed since a previous bolus was administered to the user. However, the BT cannot decrease more than a minimum insulin value. Such a configuration maintains a good balance between user safety and user disruption. Indeed, having a minimum value after a certain amount of time prevents a user notification with a medication dosage that is too low to be relevant, even if the time elapsed since the last user notification issued or bolus administered is significantly greater than the TT.

[0080] According to one embodiment, the BT has a minimum insulin value, said minimum insulin value depending on the physiological impact of a unit of insulin on the user and a user preference. Such a configuration allows the system to adapt to the user.

[0081] According to a preferred embodiment, the BT has a minimum insulin value, said minimum insulin value being equal to [Math 8] max (yU, pU, yCF), where yU corresponds to a minimum quantity of insulin units that can be dispensed using the dispensing device 4 and is a pre-recorded value between half an insulin unit and 2 insulin units, pU corresponds to an amount of insulin units according to the user's preference and yCF is a compensation factor multiplied by a constant in order to take into account the user's insulin needs. Such a configuration allows the system to adapt to the user, while maintaining a better balance between user safety and user disturbance.

[0082] The plurality of disturbance thresholds includes a time threshold hereinafter referred to as TT, the TT corresponding to a minimum amount of time elapsed since a previous user notification issued to a user or a previous bolus administered to the user. Having a TT makes it possible to only issue a user notification and thus only disturb the user after a certain amount of time has elapsed since the last bolus received by the user and thus reduce the overall disturbance by the system. According to the present invention, a received bolus corresponds to a certain dose of insulin injected / administered into the user's body.

[0083] According to one embodiment, the notification module 26 is adapted to, when the disturbance module 25 determines that at least the BT and the TT are triggered or when at least one disturbing bypass is triggered, issue a user notification. Such a configuration makes it possible to potentially minimize the overall disturbance by the system because it potentially reduces the number of user notifications issued according to both the BT and HT.

[0084] According to the preferred embodiment, the notification module 26 is adapted to, when the disturbance module 25 determines that at least the BT, HT and TT are triggered or when at least one disturbance bypass is triggered, issuing a user notification. Such a configuration makes it possible to potentially minimize the overall disturbance by the system because it potentially reduces the number of user notifications issued according to the BT, the IT and the TT.

[0085] The present invention also relates to a method for communicating processing information to a user, according to [Fig. 3], in which the method is implemented by the system for communicating processing information to a user previously described and comprises the following steps: - receiving data 30, the data receiving step 30 comprising receiving data comprising at least user metabolite time data - determining drug dosage 40, the drug dosage determining step 40 consisting of determining a possible drug dosage from said data; - trigger determination 50, the trigger determination step 50 consisting of determining whether said data or the possible dosage of medication triggers at least one disturbance threshold among a plurality of disturbance thresholds; and - issuing a notification 60, the notification issuing step 60 consisting of issuing a user notification to a user when it is determined, during the trigger determination step 50, that at least one threshold among the plurality of disturbance thresholds is triggered or when at least one disturbance bypass is triggered, the user notification comprising the possible dosage of medication; wherein the plurality of disturbance thresholds comprises: . a bolus threshold hereinafter referred to as BT, the BT corresponding to a minimum bolus dose; . a drug threshold hereinafter referred to as IT, the IT corresponding to a minimal dose of insulin; and . a time threshold hereinafter referred to as TT, the TT corresponding to a minimum amount of time elapsed since a previous user notification delivered to a user or a previous bolus administered to the user.

[0086] According to one embodiment, all the characteristics and advantages previously described applicable to the computerized system, such as specific characteristics of disturbance thresholds for example, are also applicable to the method.

[0087] According to one embodiment, the notification emission step 60 consists of emitting a user notification to a user when it is determined, during the de trigger termination 50, that at least the LV and the TT are triggered or when at least one disturbing flashover is triggered.

[0088] According to a preferred embodiment, the notification transmission step 60 consists of transmitting a user notification to a user when it is determined, during the triggering determination step 50, that at least the BT, the IT and the TT are triggered or when at least one disruptive bypass is triggered.

[0089] The present invention also relates to a computer program product comprising instructions which, when the program is executed by a computer, cause the computer to execute the steps of the method of communicating processing information to a user as described above.

[0090] According to one embodiment, all the characteristics and advantages previously described applicable to the computer program product, such as specific characteristics of disturbance thresholds for example, are also applicable to the method.

[0091] Although an exemplary embodiment of the invention has been described with reference to two principal embodiments, those skilled in the art will understand that various changes, omissions, and / or additions may be made, and equivalents may be substituted for elements thereof without departing from the spirit and scope of the invention. In addition, numerous modifications may be made to adapt a particular situation or material to the teachings of the invention without departing from the scope thereof. Accordingly, it is to be understood that the invention is not limited to the particular embodiment disclosed as the best mode contemplated for carrying out this invention, but that the invention will include all embodiments falling within the scope of the appended claims. Furthermore, unless otherwise indicated, any use of the terms first, second, etc. does not denote any order or importance, but rather the terms first, second, etc.are used to distinguish one element from another.

Claims

Claims

1. A computerized system (1) for communicating treatment information to a user, wherein the computerized system (1) comprises: . a memory (22) storing data comprising, at least, temporal data of user metabolites; .a processor (23) comprising: - a dose determination module (24) adapted to determine a possible dosage of medication on the basis of said data; - a disturbance module (25) adapted to determine whether said data or the possible dosage of medication triggers at least one disturbance threshold among a plurality of disturbance thresholds; - a notification module (26) adapted to, when the disturbance module (25) determines that the at least one disturbance threshold is triggered or when at least one disturbance bypass is triggered, issue a user notification, the user notification being issued to the user and comprising the possible dosage of medication; wherein the plurality of disturbance thresholds comprises: . a bolus threshold hereinafter referred to as BT, the BT corresponding to a minimum possible dosage of medication; . a medication threshold hereinafter referred to as IT, the IT corresponding to a minimum possible dosage of medication; and .a time threshold hereinafter referred to as TT, the TT corresponding to a minimum amount of time elapsed since a previous user notification issued to a user or a previous bolus administered to the user.

2. A computerized system (1) for communicating processing information to a user according to claim 1, wherein the notification module (26) is adapted to, when the disturbance module (25) determines that at least the BT and the TT are triggered or when at least one disturbing bypass is triggered, issue a user notification.

3. A computerized system (1) for communicating processing information to a user according to claim 2, wherein the notification module (26) is adapted to, when the disturbance module (25) determines that at least the BT, the IT and the TT are triggered or when at least one disturbing bypass is triggered, issue a noti- user information.

4. A computerized system (1) for communicating treatment information to a user according to any one of claims 1 to 3, wherein the IT depends on a minimum blood sugar level to be corrected and a compensation factor.

5. A computerized system (1) for communicating treatment information to a user according to any one of claims 1 to 4, wherein the BT decreases based on an amount of time elapsed since a previous user notification was issued to a user or a previous bolus was administered to the user.

6. A computerized system (1) for communicating treatment information to a user according to claim 5, wherein the BT has a minimum medication value after a certain amount of time has elapsed since a previous user notification was issued to a user or a previous bolus was administered to the user.

7. A computerized system (1) for communicating processing information to a user according to any one of claims 1 to 6, wherein a disruptive bypass is an emergency bypass, said emergency bypass being triggered in which a risk to the user is identified from the data.

8. A method of communicating treatment information to a user, characterized in that the method is implemented by a computerized system and comprises the following steps: - data reception (30), the data reception step (30) comprising receiving data comprising at least user metabolite time data; - drug dosage determination (40), the drug dosage determination step (40) comprising determining a possible drug dosage from said data; - trigger determination (50), the trigger determination step (50) comprising determining whether said data or the possible drug dosage triggers at least one disturbance threshold from a plurality of disturbance thresholds;and - issuing a notification (60), the notification issuing step (60) consisting of issuing a user notification to a user when it is determined, during the triggering determination step (50), that at least one threshold among the plurality of disturbance thresholds is triggered or when at least one disturbance bypass is; triggered, the user notification comprising the possible drug dosage; wherein the plurality of disturbance thresholds comprises: . a bolus threshold hereinafter referred to as BT, the BT corresponding to a minimum possible drug dosage; . a drug threshold hereinafter referred to as IT, HT corresponding to a minimum possible drug dosage; and . a time threshold hereinafter referred to as TT, the TT corresponding to a minimum amount of time elapsed since a previous user notification delivered to a user or a previous bolus administered to the user.

9. A method of communicating processing information to a user according to claim 8, wherein the notification issuing step (60) comprises issuing a user notification to a user when it is determined, in the trigger determining step (50), that at least the BT and the TT are triggered or when at least one disruptive bypass is triggered.

10. A method of communicating processing information to a user according to claim 9, wherein the notification issuing step (60) comprises issuing a user notification to a user when it is determined, in the trigger determining step (50), that at least the BT, the IT and the TT are triggered or when at least one disruptive bypass is triggered.

11. A method of communicating treatment information to a user according to any one of claims 8 to 10, wherein the IT depends on a minimum blood glucose level to be corrected and a compensation factor.

12. A method of communicating treatment information to a user according to any one of claims 8 to 11, wherein the BT decreases depending on the amount of time elapsed since a previous user notification was issued to a user or a previous bolus was administered to the user.

13. A method of communicating treatment information to a user according to claim 12, wherein the BT has a minimum value after a certain amount of time has elapsed since a previous user notification was issued to a user or a previous bolus was administered to the user.

14. Method of communicating processing information to a user according to any one of claims 8 to 13, wherein a disruptive bypass is an emergency bypass, said emergency bypass being triggered in which a risk to the user is identified from the data.

15. A computer program product comprising instructions which, when the program is executed by a computer, cause the computer to perform the steps of the method according to any one of claims 8 to 14.